Nelsen Robert
SEC-identified person · CIK 1219042 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kardigan, Inc. KARD | Director | filed 2026–2026 |
| Prime Medicine, Inc. PRME | Director | filed 2022–2026 |
| Sana Biotechnology, Inc. SANA | Director | filed 2021–2026 |
| Seaport Therapeutics, Inc. SPTX | Officer | filed 2026–2026 |
| Lyell Immunopharma, Inc. LYEL | Director | filed 2021–2026 |
| Metsera, Inc. MTSR | Director | filed 2025–2025 |
| Neumora Therapeutics, Inc. NMRA | Officer | filed 2023–2025 |
| Maze Therapeutics, Inc. MAZE | Officer | filed 2025–2025 |
| Rapport Therapeutics, Inc. RAPP | Officer | filed 2024–2024 |
| Vir Biotechnology, Inc. VIR | Director | filed 2019–2024 |
| Boundless Bio, Inc. BOLD | Officer | filed 2024–2024 |
| DA32 Life Science Tech Acquisition Corp. DALS | Officer | filed 2021–2023 |
| Codiak Biosciences, Inc. CDAK | Officer | filed 2020–2022 |
| Erasca, Inc. ERAS | Officer | filed 2021–2021 |
| Beam Therapeutics Inc. BEAM | Director | filed 2020–2021 |
| Verve Therapeutics, Inc. VERV | Officer | filed 2021–2021 |
| Denali Therapeutics Inc. DNLI | Director | filed 2017–2021 |
| Karuna Therapeutics, Inc. KRTX | Director | filed 2019–2021 |
| Revolution Healthcare Acquisition Corp. REVH | Director | filed 2021–2021 |
| 908 Devices Inc. MASS | Officer | filed 2020–2020 |
| Quanterix Corp QTRX | Officer | filed 2017–2020 |
| Metacrine, Inc. MTCR | Officer | filed 2020–2020 |
| Unity Biotechnology, Inc. UBX | Director | filed 2018–2020 |
| Syros Pharmaceuticals, Inc. SYRS | Director | filed 2016–2019 |
| Q32 Bio Inc. QTTB | Officer | filed 2018–2019 |
| Sienna Biopharmaceuticals, Inc. SNNA | Director | filed 2017–2019 |
| Gossamer Bio, Inc. GOSS | Officer | filed 2019–2019 |
| Twist Bioscience Corp TWST | Officer | filed 2018–2018 |
| Scholar Rock Holding Corp SRRK | Officer | filed 2018–2018 |
| Ruthigen, Inc. RTGN | Officer | filed 2015–2018 |
| Juno Therapeutics, Inc. JUNO | Director | filed 2014–2018 |
| Agios Pharmaceuticals, INC. AGIO | Director | filed 2013–2017 |
| Xtera Communications, INC. XCOM | Officer | filed 2015–2016 |
| Impinj INC PI | Officer | filed 2016–2016 |
| Phaserx, INC. PZRX | Officer | filed 2016–2016 |
| Sage Therapeutics, Inc. SAGE | Director | filed 2014–2015 |
| Adesto Technologies Corp IOTS | Officer | filed 2015–2015 |
| VBI Vaccines INC. plcc | Officer | filed 2014–2015 |
| Kythera Biopharmaceuticals INC KYTH | Director | filed 2012–2015 |
| Bellerophon Therapeutics, Inc. BLPH | Director | filed 2015–2015 |
| Receptos, Inc. RCPT | Officer | filed 2013–2014 |
| Achaogen, Inc. AKAO | Officer | filed 2014–2014 |
| Fate Therapeutics INC fate | Director | filed 2013–2013 |
| Bluebird bio, Inc. BLUE | Officer | filed 2013–2013 |
| Neurogesx Inc NGSX | Director | filed 2007–2012 |
| Trubion Pharmaceuticals, Inc TRBN | Officer | filed 2006–2010 |
| Celebrate Express, INC. bday | Officer | filed 2008–2008 |
| Adolor Corp adlr | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.